Beijing Chunlizhengda Medical Instruments Co., Ltd., commonly referred to as Chunlizhengda, is a leading player in the medical device industry, headquartered in Beijing, China. Established in 2000, the company has made significant strides in the development and manufacturing of high-quality medical instruments, particularly in the fields of orthopaedics and minimally invasive surgery. Chunlizhengda's core product offerings include advanced surgical instruments and innovative medical solutions that cater to both domestic and international markets. Renowned for their precision and reliability, these products have positioned the company as a trusted name among healthcare professionals. With a commitment to research and development, Chunlizhengda continues to enhance its market presence, contributing to the advancement of medical technology and improving patient outcomes globally.
How does Beijing Chunlizhengda Medical Instruments Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Beijing Chunlizhengda Medical Instruments Co's score of 27 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Beijing Chunlizhengda Medical Instruments Co., Ltd. reported total carbon emissions of approximately 3,239,250 kg CO2e. This figure includes 19,370 kg CO2e from Scope 1 emissions, 3,216,900 kg CO2e from Scope 2 emissions, and 6,980 kg CO2e from Scope 3 emissions. The company's emissions for 2021 were lower, with total emissions of about 2,113,900 kg CO2e, comprising 10,910 kg CO2e from Scope 1, 2,092,900 kg CO2e from Scope 2, and 3,990 kg CO2e from Scope 3. Beijing Chunlizhengda has set ambitious reduction targets, aiming for a 35% decrease in CO2 emissions per RMB 10,000 of products by 2030, relative to a baseline of 0.0243 tonnes of CO2 emissions per RMB 10,000 in 2020. This target applies to both Scope 1 and Scope 2 emissions, with a goal of achieving 0.0157% emissions intensity by 2030. The company has not reported any emissions data for 2020, indicating a potential gap in their historical emissions tracking. However, their commitment to reducing emissions aligns with industry standards and reflects a proactive approach to climate responsibility.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 10,910 | 00,000 |
| Scope 2 | 2,092,900 | 0,000,000 |
| Scope 3 | 3,990 | 0,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Beijing Chunlizhengda Medical Instruments Co has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
